Use of a COPD care pathway heightened the odds for a pulmonary rehabilitation referral and home discharge in hospitalized ...

Adults hospitalized for acute COPD exacerbation faced elevated odds for all-cause mortality and ICU admission if they had end-stage renal disease and were on dialysis, according to data presented at ...

Merck & Co., Inc. acquires Cidara Therapeutics, Inc. for $9.2bn, boosting its pipeline with CD388's strong flu data. Click ...

Biologic therapies targeting eosinophilic inflammation hold promise for COPD management. Realising their benefits will ...

ERS 2025 covered lung cancer treatment advances like robot-assisted bronchoscopy with integrated cone-beam CT (RAB-CBCT) and ...

Key points A 53-year-old woman with rectosigmoid adenocarcinoma was seen in the radiation oncology clinic for her fifth and final fraction of neoadjuvant radiotherapy, where she reported chills, ...

The Company reported a net loss of approximately $4.0 million, or $0.06 per share, for the three months ended September 30, ...

Public meeting on Nov. 6 sees several people criticize town and GNWT for what’s been done since original advisory earlier ...

Pharmaceuticals’ treatment of pulmonary arterial hypertension was granted FDA orphan designation status, according to a post to ...

Results reported for Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis. Company plans to meet with the FDA to ...

Live demonstrations ofNanox.ARC X to be featured at RSNA booth (3914, South Hall Level 3) every 30 minutesInnovation Theaterpresentationto ...

Roivant Sciences Ltd.'s innovative model and breakthrough autoimmune drug pipeline make it a strong buy. Click here to read ...